Glenmark Pharmaceuticals Ltd (stock symbol: GLENMARK.NS) is a publicly traded company listed on NSE, operating within the PHARMA sector. As of the latest trading session, Glenmark Pharmaceuticals Ltd is trading at ₹983.25 with a market capitalization of 262.00B. The stock has experienced a gain of 0.27% in today's trading, reflecting bullish sentiment among market participants.
The day's trading range has been between ₹970.76 (low) and ₹989.64 (high), with an opening price of ₹989.82 compared to the previous close of ₹980.60. Approximately 2.01M shares have changed hands, indicating strong liquidity and active investor interest in this stock.
Key Market Metrics for GLENMARK.NS:
Investors tracking GLENMARK.NS should note that the P/E ratio of 21.42 indicates moderate market expectations for future growth. Understanding these fundamental metrics alongside technical price action gives investors a comprehensive view of Glenmark Pharmaceuticals Ltd's market position and future prospects on NSE.
The PHARMA sector has been an area of consistent interest for market participants. Companies within this sector demonstrate varying performance based on macroeconomic factors, regulatory changes, and company-specific developments. Glenmark Pharmaceuticals Ltd continues to adapt to market dynamics while maintaining its competitive positioning.
For technical analysis, traders monitor several key levels for GLENMARK.NS: support at ₹970.76 and ₹980.60, and resistance at ₹989.64. The P/E ratio of 21.42 provides valuation context, helping investors determine if Glenmark Pharmaceuticals Ltd is trading at a premium or discount relative to its earnings potential. Regular monitoring of quarterly results, management commentary, and sector-wide trends will help investors stay informed about GLENMARK.NS's trajectory on NSE.
The current live price of Glenmark Pharmaceuticals Ltd (GLENMARK.NS) is ₹983.25 as of the most recent market data update on NSE. This price reflects the last traded value and changes in real-time during market hours. Today's trading session opened at ₹989.82, compared to the previous day's close of ₹980.60.
The intraday price action for GLENMARK.NS shows a high of ₹989.64 and a low of ₹970.76, giving the stock a daily trading range of approximately ₹18.88. The stock has experienced a gain of 0.27% in today's session. The total volume traded stands at approximately 2.01M shares.
Key Market Metrics for GLENMARK.NS:
Market participants tracking GLENMARK.NS should note that these prices are live and updated from market data providers. The market cap of 262.00B places Glenmark Pharmaceuticals Ltd among significant companies listed on NSE. Trading volume of 2.01M shares suggests strong liquidity and active investor interest in this stock.
Understanding the price history of Glenmark Pharmaceuticals Ltd (GLENMARK.NS) is essential for both technical and fundamental analysis. The stock's current price of ₹983.25 can be better understood in the context of its recent trading patterns and long-term trends on NSE.
Today's price action shows GLENMARK.NS opening at ₹989.82 compared to the previous close of ₹980.60. The intraday high of ₹989.64 and low of ₹970.76 represent the price boundaries for today's trading session. The positive movement of 0.27% provides insight into the day's market sentiment toward Glenmark Pharmaceuticals Ltd.
For technical analysis, traders monitor several key levels for GLENMARK.NS:
The P/E ratio of 21.42 provides a valuation benchmark comparing Glenmark Pharmaceuticals Ltd's stock price to its earnings per share. These fundamental metrics, combined with technical price action, give investors a comprehensive view of GLENMARK.NS's current market position and future prospects on NSE.
Investors are advised to use the interactive chart above to analyze GLENMARK.NS's price trends across different timeframes — from intraday 1D charts for short-term traders to 1Y charts for long-term investors. The combination of fundamental analysis and technical chart patterns helps in making well-informed decisions about Glenmark Pharmaceuticals Ltd stock in the PHARMA sector.
Indian investors looking to purchase Glenmark Pharmaceuticals Ltd (GLENMARK.NS) shares have several reliable options through registered stockbrokers and trading platforms. The process of buying GLENMARK.NS shares in India involves opening a demat and trading account with a SEBI-registered broker, completing the KYC (Know Your Customer) process, and funding the account to start trading. Below are the most popular platforms for investing in GLENMARK.NS and other stocks on NSE.
Zerodha is India's largest retail stockbroker by active clients and offers a seamless platform for buying GLENMARK.NS shares. With Zerodha's Kite platform, you can trade Glenmark Pharmaceuticals Ltd stocks on NSE and BSE with zero brokerage on equity delivery trades. The account opening process is fully digital and can be completed in minutes. Open a Zerodha account here to start investing in GLENMARK.NS with zero brokerage on delivery trades and flat €20 per trade on intraday and F&O.
Groww offers an intuitive mobile-first investment platform that is perfect for beginners looking to buy Glenmark Pharmaceuticals Ltd shares. With a simple interface and educational resources, Groww makes it easy to invest in GLENMARK.NS and thousands of other stocks and mutual funds. The platform offers zero account opening fees and zero brokerage on equity delivery. Sign up on Groww to begin your investment journey with Glenmark Pharmaceuticals Ltd shares.
Angel One is another excellent choice for trading GLENMARK.NS stocks, offering advanced charting tools, research reports, and expert recommendations. The platform provides free equity delivery trades and a powerful mobile trading app. Angel One's research team publishes regular analysis on Glenmark Pharmaceuticals Ltd and other PHARMA sector stocks to help you make informed decisions. Open an Angel One account and get access to expert stock recommendations and advanced trading tools.
Steps to Buy GLENMARK.NS Shares in India: